Literature DB >> 9593294

ClpX and ClpP are essential for the efficient acquisition of genes specifying type IA and IB restriction systems.

S Makovets1, A J Titheradge, N E Murray.   

Abstract

Efficient acquisition of genes that encode a restriction and modification (R-M) system with specificities different from any already present in the recipient bacterium requires the sequential production of the new modification enzyme followed by the restriction activity in order that the chromosome of the recipient bacterium is protected against attack by the restriction endonuclease. We show that ClpX and ClpP, the components of ClpXP protease, are necessary for the efficient transmission of the genes encoding EcoKI and EcoAI, representatives of two families of type I R-M systems, thus implicating ClpXP in the modulation of restriction activity. Loss of ClpX imposed a bigger barrier than loss of ClpP, consistent with a dual role for ClpX, possibly as a chaperone and as a component of the ClpXP protease. Transmission of genes specifying EcoKI was more dependent on ClpX and ClpP than transmission of the genes for EcoAI. Sensitivity to absence of the protease was also influenced by the mode of gene transfer; conjugative transfer and transformation were more dependent on ClpXP than transduction. In the absence of either ClpX or ClpP transfer of the EcoKI genes by P1-mediated transduction was impaired, transfer of the EcoAI genes was not.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593294     DOI: 10.1046/j.1365-2958.1998.00767.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  18 in total

1.  Regulation of endonuclease activity by proteolysis prevents breakage of unmodified bacterial chromosomes by type I restriction enzymes.

Authors:  S Makovets; V A Doronina; N E Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Type I restriction systems: sophisticated molecular machines (a legacy of Bertani and Weigle).

Authors:  N E Murray
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

Review 3.  Nucleoside triphosphate-dependent restriction enzymes.

Authors:  D T Dryden; N E Murray; D N Rao
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

4.  Cosmid-based system for transient expression and absolute off-to-on transcriptional control of Escherichia coli genes.

Authors:  John E Cronan
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

5.  Evidence for multiple levels of regulation of Oenococcus oeni clpP-clpL locus expression in response to stress.

Authors:  Charlotte Beltramo; Cosette Grandvalet; Fabrice Pierre; Jean Guzzo
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

6.  Roles of PriA protein and double-strand DNA break repair functions in UV-induced restriction alleviation in Escherichia coli.

Authors:  Ivana Ivancić-Bacće; Ignacija Vlasić; Gordana Cogelja-Cajo; Krunoslav Brcić-Kostić; Erika Salaj-Smic
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

7.  McrBs, a modulator peptide for McrBC activity.

Authors:  D Panne; E A Raleigh; T A Bickle
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

8.  The ClpXP ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar typhimurium.

Authors:  Toshifumi Tomoyasu; Tomiko Ohkishi; Yoshifumi Ukyo; Akane Tokumitsu; Akiko Takaya; Masato Suzuki; Kachiko Sekiya; Hidenori Matsui; Kazuhiro Kutsukake; Tomoko Yamamoto
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

9.  Tracking EcoKI and DNA fifty years on: a golden story full of surprises.

Authors:  Wil A M Loenen
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

10.  Resolution of joint molecules by RuvABC and RecG following cleavage of the Escherichia coli chromosome by EcoKI.

Authors:  Laura Wardrope; Ewa Okely; David Leach
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.